Use of off-label compounded oral sildenafil in the management of persistent pulmonary hypertension of the newborn: A case report

0Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

Abstract

We report a case of a newborn with persistent pulmonary hypertension (PPHN) due to meconium aspiration syndrome with associated lung collapse. Echocardiogram revealed features of persistent pulmonary hypertension. He was treated with compounded oral sildenafil. Oral sildenafil has proven to be effective and safe in the management of PPHN in neonates with persistent pulmonary hypertension. Therefore, in situations where inhaled nitric oxide is not available it may be used as an alternative therapy in PPHN. Further randomized controlled studies are needed to determine its efficacy and pharmacokinetics.

Cite

CITATION STYLE

APA

Daniyan, O., Ezeanosike, O., Obu, D., & Ujunwa, F. (2022). Use of off-label compounded oral sildenafil in the management of persistent pulmonary hypertension of the newborn: A case report. Journal of Cardiovascular and Thoracic Research, 14(2), 141–143. https://doi.org/10.34172/jcvtr.2022.03

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free